• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经瞬时弹性成像测得的肝脏硬度与新冠病毒病(COVID-19)的疾病严重程度相关。

Liver stiffness by transient elastography accompanies illness severity in COVID-19.

作者信息

Effenberger Maria, Grander Christoph, Fritsche Gernot, Bellmann-Weiler Rosa, Hartig Frank, Wildner Sophie, Seiwald Stefanie, Adolph Timon Erik, Zoller Heinz, Weiss Gunter, Tilg Herbert

机构信息

Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology and Metabolism, Medical University of Innsbruck, Innsbruck, Austria.

Department of Internal Medicine II, Infectious Disease, Pulmonology & Rheumatology, Medical University of Innsbruck, Innsbruck, Austria.

出版信息

BMJ Open Gastroenterol. 2020 Jul;7(1). doi: 10.1136/bmjgast-2020-000445.

DOI:10.1136/bmjgast-2020-000445
PMID:32665398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10577726/
Abstract

OBJECTIVE

Severe liver damage is associated with worse outcome in COVID-19. Our aim was to explore the degree of liver damage, liver stiffness (LS) and severity of illness in patients with COVID-19.

DESIGN

We investigated 32 patients with COVID-19 admitted to the University Hospital of Innsbruck in a prospective cross-sectional study. We performed laboratory testing, liver and spleen sonography and elastography to measure organ stiffness.

RESULTS

12 patients (38%) showed elevated aminotransferases and gamma-glutamyltransferase levels. LS was positively correlated with elevated aminotransferase levels in patients with COVID-19 compared with those without elevated enzymes. Even mild liver damage raised LS significantly in COVID-19 as it was in patients with gastrointestinal symptoms. Furthermore, higher LS measurements were significantly associated with illness severity like pneumonia, need for mechanical ventilation, and even death.

CONCLUSION

Transient elastography is a useful and non-invasive tool to assess onset and severity of acute liver injury in patients with COVID-19 patients. Increased LS seems to be predictive for a more severe and complicated course of disease.

摘要

目的

在新型冠状病毒肺炎(COVID-19)中,严重肝损伤与更差的预后相关。我们的目的是探讨COVID-19患者的肝损伤程度、肝脏硬度(LS)和疾病严重程度。

设计

我们在一项前瞻性横断面研究中调查了因COVID-19入住因斯布鲁克大学医院的32例患者。我们进行了实验室检测、肝脏和脾脏超声检查以及弹性成像以测量器官硬度。

结果

12例患者(38%)转氨酶和γ-谷氨酰转移酶水平升高。与转氨酶未升高的COVID-19患者相比,COVID-19患者的LS与转氨酶水平升高呈正相关。即使是轻度肝损伤也会使COVID-19患者的LS显著升高,就像有胃肠道症状的患者一样。此外,更高的LS测量值与肺炎、机械通气需求甚至死亡等疾病严重程度显著相关。

结论

瞬时弹性成像对于评估COVID-19患者急性肝损伤的发生和严重程度是一种有用的非侵入性工具。LS升高似乎预示着疾病的病程更严重和复杂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06de/10577726/d50f7a1df22f/bmjgast-2020-000445f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06de/10577726/a17cedf416e1/bmjgast-2020-000445f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06de/10577726/d4ca511be432/bmjgast-2020-000445f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06de/10577726/d50f7a1df22f/bmjgast-2020-000445f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06de/10577726/a17cedf416e1/bmjgast-2020-000445f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06de/10577726/d4ca511be432/bmjgast-2020-000445f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06de/10577726/d50f7a1df22f/bmjgast-2020-000445f03.jpg

相似文献

1
Liver stiffness by transient elastography accompanies illness severity in COVID-19.经瞬时弹性成像测得的肝脏硬度与新冠病毒病(COVID-19)的疾病严重程度相关。
BMJ Open Gastroenterol. 2020 Jul;7(1). doi: 10.1136/bmjgast-2020-000445.
2
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.SARS-CoV-2 感染肝脏直接导致 COVID-19 患者肝损伤。
J Hepatol. 2020 Oct;73(4):807-816. doi: 10.1016/j.jhep.2020.05.002. Epub 2020 May 11.
3
Liver injury in severe COVID-19 infection: current insights and challenges.严重 COVID-19 感染中的肝损伤:当前的认识和挑战。
Expert Rev Gastroenterol Hepatol. 2020 Oct;14(10):879-884. doi: 10.1080/17474124.2020.1794812. Epub 2020 Jul 17.
4
Correlation analysis of coagulation dysfunction and liver damage in patients with novel coronavirus pneumonia: a single-center, retrospective, observational study.新型冠状病毒肺炎患者凝血功能障碍与肝损伤的相关性分析:一项单中心、回顾性、观察性研究。
Ups J Med Sci. 2020 Nov;125(4):293-296. doi: 10.1080/03009734.2020.1822960. Epub 2020 Sep 29.
5
Liver injury in COVID-19: What do we know now?新型冠状病毒肺炎中的肝损伤:我们目前了解多少?
Hepatobiliary Pancreat Dis Int. 2020 Oct;19(5):407-408. doi: 10.1016/j.hbpd.2020.07.009. Epub 2020 Jul 23.
6
Abdominal fluid samples (negative for SARS-CoV-2) from a critically unwell patient with respiratory COVID-19.一名患有呼吸道新型冠状病毒肺炎的危重症患者的腹腔积液样本(严重急性呼吸综合征冠状病毒2检测呈阴性)
Br J Surg. 2020 Jul;107(8):e259-e260. doi: 10.1002/bjs.11713. Epub 2020 May 26.
7
Mediastinal lymphadenopathy in patients with severe COVID-19.重症新型冠状病毒肺炎患者的纵隔淋巴结肿大
Lancet Infect Dis. 2020 Nov;20(11):1230. doi: 10.1016/S1473-3099(20)30310-8. Epub 2020 Apr 21.
8
Etiology and management of liver injury in patients with COVID-19.新型冠状病毒肺炎患者肝损伤的病因和处理。
World J Gastroenterol. 2020 Aug 28;26(32):4753-4762. doi: 10.3748/wjg.v26.i32.4753.
9
Severe COVID-19 patients with liver injury: a seven-case series.严重 COVID-19 合并肝损伤患者:七例病例系列报告。
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7855-7860. doi: 10.26355/eurrev_202007_22290.
10
Gastrointestinal and liver manifestations of COVID-19.新型冠状病毒肺炎的胃肠道和肝脏表现
Saudi J Gastroenterol. 2020 Sep-Oct;26(5):226-232. doi: 10.4103/sjg.SJG_147_20.

引用本文的文献

1
Liver dysfunction in adults with COVID-19 infection: A longitudinal study with transient elastography evaluation.新型冠状病毒肺炎感染成年患者的肝功能障碍:一项使用瞬时弹性成像评估的纵向研究
JGH Open. 2024 Aug 7;8(8):e13118. doi: 10.1002/jgh3.13118. eCollection 2024 Aug.
2
Association of Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease with COVID-19-Related Intensive Care Unit Outcomes: A Systematic Review and Meta-Analysis.非酒精性脂肪性肝病和代谢相关脂肪性肝病与 COVID-19 相关重症监护病房结局的关联:系统评价和荟萃分析。
Medicina (Kaunas). 2023 Jul 3;59(7):1239. doi: 10.3390/medicina59071239.
3

本文引用的文献

1
Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'.回复:“无证据表明代谢相关脂肪性肝病中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的肝脏摄取增加” 。
J Hepatol. 2020 Sep;73(3):718-719. doi: 10.1016/j.jhep.2020.04.039. Epub 2020 May 6.
2
Liver impairment associated with disease progression in COVID-19 patients.COVID-19 患者疾病进展相关的肝损伤。
Liver Int. 2020 Sep;40(9):2308. doi: 10.1111/liv.14481.
3
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies.
Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis.
非酒精性脂肪肝和代谢相关脂肪性肝病与 COVID-19 结局的关系:系统评价和荟萃分析。
World J Gastroenterol. 2023 Jun 7;29(21):3362-3378. doi: 10.3748/wjg.v29.i21.3362.
4
COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes.COVID-19 引起的转氨血症和高胆红素血症:表现和结局。
World J Gastroenterol. 2023 Feb 21;29(7):1123-1130. doi: 10.3748/wjg.v29.i7.1123.
5
Liver involvement in patients with COVID-19 infection: A comprehensive overview of diagnostic imaging features.COVID-19 感染患者的肝脏受累:诊断影像学特征的全面概述。
World J Gastroenterol. 2023 Feb 7;29(5):834-850. doi: 10.3748/wjg.v29.i5.834.
6
Prevention, diagnostic evaluation, management and prognostic implications of liver disease in critically ill patients with COVID-19.COVID-19危重症患者肝病的预防、诊断评估、管理及预后影响
World J Clin Cases. 2023 Jan 26;11(3):514-527. doi: 10.12998/wjcc.v11.i3.514.
7
An overview of SARS-COV-2-related hepatic injury.新型冠状病毒肺炎相关肝损伤概述
Hepatol Forum. 2021 Sep 15;2(3):122-127. doi: 10.14744/hf.2021.2021.0020. eCollection 2021 Sep.
8
The severity of portal hypertension by a non-invasive assessment: acoustic structure quantification analysis of liver parenchyma.通过非侵入性评估确定门静脉高压症的严重程度:肝脏实质的声学结构定量分析。
BMC Med Imaging. 2022 May 12;22(1):85. doi: 10.1186/s12880-022-00817-2.
9
Patterns of liver profile disturbance in patients with COVID-19.新型冠状病毒肺炎患者的肝功能异常模式
World J Clin Cases. 2022 Mar 6;10(7):2063-2071. doi: 10.12998/wjcc.v10.i7.2063.
10
COVID-19 pathophysiology and ultrasound imaging: A multiorgan review.COVID-19 病理生理学与超声成像:多器官综述。
J Clin Ultrasound. 2022 Mar;50(3):326-338. doi: 10.1002/jcu.23160. Epub 2022 Feb 26.
通过尸体核心活检对 2019 年新型冠状病毒病(COVID-19)的病理学研究。
Mod Pathol. 2020 Jun;33(6):1007-1014. doi: 10.1038/s41379-020-0536-x. Epub 2020 Apr 14.
4
Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China.COVID-19 患者的肝损伤:来自中国武汉市单个中心的 115 例回顾性分析。
Liver Int. 2020 Sep;40(9):2095-2103. doi: 10.1111/liv.14455. Epub 2020 Apr 28.
5
Clinical and virological data of the first cases of COVID-19 in Europe: a case series.欧洲首批 COVID-19 病例的临床和病毒学数据:一项病例系列研究。
Lancet Infect Dis. 2020 Jun;20(6):697-706. doi: 10.1016/S1473-3099(20)30200-0. Epub 2020 Mar 27.
6
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.74 例伴有胃肠道症状的 2019 年冠状病毒病(COVID-19)患者的流行病学、临床和病毒学特征。
Gut. 2020 Jun;69(6):1002-1009. doi: 10.1136/gutjnl-2020-320926. Epub 2020 Mar 24.
7
COVID-19 and the liver: little cause for concern.新冠病毒与肝脏:无需过度担忧。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):529-530. doi: 10.1016/S2468-1253(20)30084-4. Epub 2020 Mar 20.
8
Autopsy in suspected COVID-19 cases.疑似 COVID-19 病例的尸检。
J Clin Pathol. 2020 May;73(5):239-242. doi: 10.1136/jclinpath-2020-206522. Epub 2020 Mar 20.
9
Liver injury in COVID-19: management and challenges.新型冠状病毒肺炎中的肝损伤:管理与挑战
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.
10
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.